Page 479 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 479

CHAPTER 23  Cancer of the Gastrointestinal Tract  457


           tumors. 353–366,373  With respect to the massive form of HCC, most   TABLE 23.7     Common Clinicopathologic
           clinical signs are related to the mechanical mass effect of the tumor   Abnormalities in Cats and Dogs with
           and only rarely to any systemic effects of the tumor or hepatic
  VetBooks.ir  insufficiency. The most common presenting signs are nonspecific,   Parameter  Hepatobiliary Tumors  Dog (%)
                                                                                         Cat (%)
           such as inappetence, weight loss, lethargy, vomiting, polydip-
           sia–polyuria, and ascites. 353–366,373  Weakness, ataxia, and seizures   Leukocytosis     54–73
           are uncommon and may be caused by hepatic encephalopathy,
           paraneoplastic hypoglycemia, or central nervous system metasta-  Anemia                   27–51
           sis. 357,361,388  Icterus is more common in dogs with extrahepatic   Hypoalbuminemia      52–83
           bile duct carcinomas and diffuse neuroendocrine tumors. 354,357,364
           Hemoperitoneum secondary to rupture of massive HCC has been   Increased ALP   10–64       61–100
           reported in two dogs. 389  Physical examination findings are often   Increased ALT  10–78  44–75
           unrewarding. A cranial abdominal mass is palpable in up to 75%
           of cats and dogs with liver tumors, although palpation can be   Increased AST  15–78      56–100
           misleading because hepatic enlargement may be either absent in   Increased GGT  78        39
           nodular and diffuse forms of liver tumors or missed because of the
           location of the liver in the cranial abdominal cavity deep to the   Increased total bilirubin  33–78  18–33
           costal arch. 353–366                                    Increased serum bile acids  67    50–75
                                                                   ALP, Alkaline phosphatase; ALT, alanine transferase; AST, aspartate aminotransferase; GGT,
           Diagnostic Techniques and Workup                        γ-glutamyltransferase.

           Laboratory Tests
           Hematologic  and  serum biochemical  abnormalities  are usually   α-Fetoprotein, an oncofetal glycoprotein, is used in the diag-
           nonspecific. Leukocytosis, anemia, and thrombocytosis are com-  nosis, monitoring response to treatment, and prognostication
           mon in dogs with liver tumors. 353–366  Anemia is usually mild and   of  HCC  in  humans. 370   In  dogs,  serum  levels  of  α-fetoprotein
           nonregenerative. 357,363  Thrombocytosis is seen in approximately   are increased in 75% of HCC and 55% of bile duct carcino-
           50% of dogs with massive HCC. 363 Anemia and thrombocytope-  mas. 393,394  However, α-fetoprotein has limited value in the diag-
           nia are relatively common in dogs with primary and metastatic   nosis and treatment monitoring of canine HCC, as serum levels
           hepatic HSAs. 355  Prolonged coagulation times (e.g., increased   of α-fetoprotein are also increased in other types of liver tumors,
           prothrombin time, thrombin time, and activated partial throm-  such as bile duct carcinoma and lymphoma, and nonneoplastic
           boplastin time) and specific clotting factor abnormalities (e.g.,   hepatic disease. 394,395  Hyperferritinemia is common in dogs with
           decreased factor VIII:C and increased factor VIII:RA and fibrino-  HS and immune-mediated hemolytic anemia (IMHA); thus, once
           gen degradation products) have been identified in dogs with hepa-  IMHA has been excluded, serum ferritin levels may be useful in
           tobiliary tumors, although these are rarely clinically relevant. 390  differentiating HS from other causes of liver disease. 396  
             Liver enzymes are commonly elevated in dogs with hepato-
           biliary tumors (Table 23.7). Increased activity of liver enzymes   Imaging
           probably reflects hepatocellular damage or biliary stasis and is
           not specific for hepatic neoplasia. 356  There is also no correlation   Radiographs, ultrasonography (US), and advanced imaging can
           between the degree of hepatic involvement and magnitude of liver   be used for the diagnosis, staging, and surgical planning of cats
           enzyme alterations. 356,363  The type of liver enzyme abnormalities   and dogs with hepatobiliary tumors. A cranial abdominal mass,
           may provide an indication of the type of tumor and differenti-  with caudal and lateral displacement of the stomach, is frequently
           ate primary and metastatic liver tumors. 391  Alkaline phosphatase   noted on abdominal radiographs of cats and dogs with massive
           (ALP) and alanine transferase (ALT) are commonly increased   liver tumors. 362,363,372  Mineralization of the biliary tree is a rare
           in dogs with primary hepatic tumors, whereas aspartate amino-  finding in dogs with bile duct carcinoma. 356  Sonographic or CT
           transferase (AST) and bilirubin are more consistently elevated in   examination is recommended because these radiographic findings
           dogs with metastatic liver tumors. 353,391  Furthermore, an AST-  are not specific for the diagnosis of a hepatic mass and do not
           to-ALT ratio less than one is consistent with HCC or bile duct   provide information on the relationship of the hepatic mass with
           carcinoma, whereas a neuroendocrine tumor or sarcoma is more   regional anatomic structures.
           likely when the ratio is greater than one. 357  In general, however,   Abdominal US or triphasic (arterial, venous, and delayed con-
           liver enzyme elevations are not specific for the diagnosis of hepa-  trast phases) CT are preferred for identifying and characterizing
           tobiliary diseases. 392  Other changes in the serum biochemical   hepatobiliary tumors in cats and dogs. 397  US examination is use-
           profile in dogs with hepatic tumors may include hypoglycemia,   ful in determining the presence of a hepatic mass and defining
           hypoalbuminemia, hyperglobulinemia, and increased preprandial   the tumor as massive, nodular, or diffuse 398–402  and, in the case of
           and postprandial bile acids. 353,354,357,361–366  Hypoglycemia is a   cats, whether the tumor is cystic or not. 372  If focal, the size and
           paraneoplastic syndrome reported secondary to hepatic adenoma   location of the mass and its relationship with adjacent anatomic
           and management is described in more detail in Chapter 5. In con-  structures, such as the gall bladder or caudal vena cava, can be
           trast to dogs, azotemia is often present in cats with hepatobiliary   assessed. 376,398–402  Tumor vascularization can be determined using
           tumors and may be the only biochemical abnormality, although   Doppler imaging techniques or triphasic CT, although the latter is
           liver enzyme abnormalities, especially ALT, AST, and total bili-  superior. 356,402  The US appearance of hepatobiliary tumors varies
           rubin, are also common and are significantly higher in cats with   and does not correlate with histologic tumor type. 376,397–406  How-
           malignant tumors. 358–360                             ever, US-guided FNA or needle-core biopsy of hepatic masses is
   474   475   476   477   478   479   480   481   482   483   484